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Abstract 
Background. The development of tailored recovery-oriented strategies in multiple sclerosis 
requires early identification of the individual’s potential for functional recovery. 
Objective. To identify predictors of visuomotor performance improvements, a proxy of 
functional recovery, using a predictive statistical model that combines demographic, clinical and 
MRI data. 
Methods. Right-handed multiple sclerosis patients underwent baseline disability assessment and 
MRI of brain structure, function and vascular health. They subsequently undertook 4 weeks’ 
right upper limb visuomotor practice. Changes in performance with practice were our outcome 
measure. We identified predictors of improvement in the training set using lasso regression; we 
calculated the best performing model in the validation set and applied this model to the test set.  
Results. Patients improved their visuomotor performance with practice. Younger age, better 
visuomotor abilities, less severe disease burden and concurrent use of preventative treatments 
predicted improvements. Neuroimaging localised outcome-relevant sensory-motor regions, 
whose microstructure and activity correlated with performance improvements.  
Conclusion. Initial characteristics, including age, disease duration, visuo-spatial abilities, hand 
dexterity, self-evaluated disease impact and the presence of disease modifying treatments, can 
predict functional recovery in individual patients, potentially improving their clinical 
management and stratification in clinical trials. MRI is a correlate of outcome, potentially 
supporting individual prognosis. 
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INTRODUCTION 
Prediction of the individual patient’s capacity for functional improvements is relevant for patient 
management in multiple sclerosis (MS), as it allows personalised recovery interventions, 
rationalisation of health resource allocation and improved stratification of patients in clinical 
trials1. Currently, prediction of functional recovery in the individual case is based solely on 
clinical experience and thus remains largely variable and inaccurate2.   
The individual’s potential for functional recovery results from the complex interaction of age, 
MS damage and disability, residual abilities and pre-morbid reserve, all of which can be captured 
by clinical measures and by MRI features3. Indeed, characteristics such as age and disease 
severity can play a role in disability development and worsening4, 5, as well as in determining 
individual outcomes during recovery-oriented interventions6-8. Brain damage and reserve, as 
assessed by MRI, can also influence the individual’s functional potential3.  
In this study, we combined demographic with baseline clinical and MRI measures to identify 
predictors of functional recovery in patients with MS. We used upper limb performance 
improvements on a visuomotor task as a proxy for functional recovery3, 9. Firstly, in a cohort of 
MS patients, we employed exploratory statistical modelling by combining measures of initial 
disability with functional and structural neuroimaging metrics, acquired before 4 weeks’ home 
practice of a standardized upper limb visuomotor task10. Secondly, using this predictive model of 
functional recovery, we identified predictors of individual performance improvements. Thirdly, 
we validated our predictive model and results in an independent patient cohort. 
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METHODS 
Patients and study design 
We recruited right-handed MS patients11 aged 18-60 years, with retained use of their right upper 
limb, no relapse or change in treatment for at least three months before study entry; no other 
neurological or psychiatric conditions. Patients were recruited within the Helen Durham Centre 
for Neuroinflammation, University Hospital of Wales, Cardiff, UK. The study was approved by 
the NHS South-West Ethics Committee. All patients provided written informed consent. 
At baseline, we collected demographic and clinical measures (Table 1), as well as functional and 
structural MRI (Table 2). Patients were instructed to practise a visuomotor task at home and 
subsequently returned to be clinically assessed. 
 
Visuomotor task and home practice 
We used a serial reaction time (SRT) task to probe recovery experimentally at baseline, while 
undergoing a brain MRI scan, and subsequently at home, on a laptop, daily for five days/week, 
for four weeks, with each practice session lasting for about 15 minutes (Fig. 1A and 
Supplementary material for details on the SRT task design and presentation). For the home 
practice, patients were asked to complete a practice log sheet on paper and weekly phone calls by 
the study team were made to ensure compliance. During the home-practice, the SRT task was 
presented on a laptop, on which the patient’s responses were recorded to be used for the analysis 
of performance improvements. 
During the SRT task, stimuli were presented in “Sequence”, “Random” or “Rest” condition. For 
each block of the SRT task, the number (accuracy) and median latency (reaction time, RT) of 
correct responses were calculated. For each day of practice, the accuracy and RT across blocks 
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were calculated (Fig. 1B, left). As accuracy can rapidly reach a plateau, we used RT to describe 
changing performance with home practice. Only patients who completed at least 50% of the 
scheduled sessions (10 days) were included in the analysis. 
For each participant and day of practice, we compared RT in Sequence versus Random blocks 
using an unpaired t-test in order to generate a contrast measure that represented Sequence-
specific performance changes. For each participant, a linear model was fitted using robustfit of 
Matlab, with practice day as the independent variable and the Sequence-specific contrast 
measure as the dependent variable. We used the individual slope of practice-related Sequence-
specific RT changes as our outcome measure of visuomotor performance changes with home 
practice (Fig. 1B, right).  
 
Demographic and clinical characteristics  
Demographic and clinical characteristics are indicated in Table 1. Disease duration was defined 
as the time (in years) between the onset of the first symptoms and the time of the study 
assessment. The date of disease onset was established from the patient’s clinical notes (whenever 
available) and confirmed during the study interview. Expanded Disability Status Scale (EDSS)12 
and MS Impact Scale 29 items (MSIS-29)13 assessed disability and disease impact; Beck 
Depression Inventory (BDI)14, State Trait Anxiety Inventory (STAI)15 scale and Modified 
Fatigue Impact Scale (MFIS)16 quantified mood, anxiety and fatigue; 9-hole peg test (9-HPT)17 
and timed 25-foot walk (T25-FW)17 characterised limb function; Rao’s Brief Repeatable 
Battery18 probed cognition.  
 
MRI acquisition and analysis 
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We acquired brain MRI scans on a 3T MRI system (GE Medical Systems, Milwaukee, WI) using 
an 8-channel receive-only head RF coil. Detailed descriptions of the MRI protocols and analysis 
pipelines are in Fig. 2 and in Supplementary material.  
MRI measures that entered the predictive modelling were selected to capture as many aspects of 
MS damage as possible in a single scan session. We considered lesional and non-lesional 
damage, functional responses and cerebral blood flow (CBF). For all MRI modalities, we 
extracted measures from predefined regions of interest (ROI-based MRI measures); functional 
MRI (fMRI) measures were defined in task-relevant ROIs. For all MRI modalities, we also 
extracted measures from areas of significant correlations with home-practice outcome (outcome-
relevant MRI measures, Table 2) for use in the models of prediction. 
 
Predictive modelling 
To predict performance improvements from baseline data, we employed a statistical learning 
approach that included a random assignment of the patients to three groups: a training set (60%) 
to establish statistical models, a validation set (20%) to select the best performing model in 
independent data, and a test set (20%) to evaluate the performance of the selected model. The 
three statistical sets underwent the same study procedures, including home practice. 
Five groups of variables were established in the training set: group A, that included demographic 
and clinical variables; group B, that included ROI-based MRI measures; group C, that included 
demographic and clinical, as well as ROI-based MRI measures; group D, that included outcome-
relevant MRI measures; group E, that included demographic and clinical, as well as outcome-
relevant MRI measures.  
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Data preparation 
Prior to modelling, all variables were z-standardized using the mean and standard deviation from 
the training set. Missing values were mean-imputed. Patients with a home-practice outcome 1.5 
interquartile ranges below the first quartile or above the third quartile of the distribution were 
excluded from modelling. Patients unable to complete the T25-FW were assigned the value of 
the slowest patient who was able to complete the test. Variables with an absolute skewness >2 
were log transformed: the scores of 9HPT and T25FW, the measures of lesion volume and the 
CBF in the putamen and globus pallidus. 
 
Statistical modelling 
Lasso regression was used for the linear modelling in the training set [Matlab (v R2015a) 
function: lasso]. This method performs variable selection and parameter estimation 
simultaneously19. Lasso regression overcomes the overfitting problems that are associated with 
traditional multiple linear regression analyses, by employing a regularisation of hyperparameter 
lambda that penalizes for the number of non-zero regression coefficients. Here, the optimal 
lambda was estimated by 7-fold cross-validation (repeated and averaged over 5 times) within the 
training set, finding lambda that minimises the mean squared error in the left-out folds. 
Correlations between predicted and actual outcome were calculated using Pearson correlation 
coefficients.  
Lasso regression was applied to each of the five groups of variables in the training set for linear 
modelling (Fig. 2), generating five linear regression models (models A-E), which consisted of a 
number of retained variables along with their parameter estimates (regression coefficients). To 
obtain an index of the predicted home-practice outcome for each patient, we applied the 
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regression coefficients of each of the five models to the baseline demographic, clinical and MRI 
data. Selection of the best performing regression model occurred by comparing the mean squared 
error (MSE) across models in the validation set. The MSE quantifies how well the predicted 
home-practice outcomes matched the measured home-practice outcomes, with a low MSE 
indicating a small difference between predicted and measured outcome. Therefore, the model 
with the lowest MSE was deemed the model best performing in the validation set and was tested 
for predictive performance in the test set by quantifying the amount of variance (R2) in the actual 
home-practice outcome that could be explained by the predicted home-practice outcome. 
 
Data Availability Statement 
Anonymized data may be shared with qualified investigators. 
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RESULTS 
Baseline characteristics 
Out of 141 recruited MS patients, 19 did not complete the study: six did not comply with 
baseline study procedures (e.g., claustrophobia in the scanner); 13 patients did not complete the 
home training programme (Fig. 1C). Out of 122 patients who completed the study, four patients 
were identified as outliers in the home-practice outcome and thus not considered for the 
modelling purposes (Fig. 1C). Fig. S1 shows the distributions of the demographic and clinical 
characteristics for the whole cohort of patients. Table 1 summarizes the characteristics of the 
whole cohort (n=118), as well as of the three groups of patients. There was no difference among 
the training, validation and test sets in their baseline demographic and clinical characteristics. 
Patients were on average in their mid 40s, mainly women and mildly to moderately disabled20, as 
suggested by measures of global disability, limb function, cognition, anxiety, mood and fatigue. 
They had a wide range of disease duration, with many patients being untreated, but (as requested 
by the eligibility criteria) in a stable phase of their disease course.  
 
Changes in behavioural measures with home practice  
Patients completed 18.8±2.2 days of home practice (min = 11, max = 24). A two-way ANOVA 
showed a significant interaction between time and condition, indicating stronger visuomotor 
performance improvements in the Sequence than in the Random for both RT [F(1,117) = 115, p 
< 0.001] and accuracy [F(1,117) = 82, p < 0.001]. There were significant Sequence-specific RT 
improvements with practice in the whole cohort of patients (mean±SD -0.45±0.33; t[117] = -15, 
p < 0.0001). The 3 groups did not differ in the mean±SD Sequence-specific RT changes (training 
set: -0.41±0.32; validation set: -0.52±0.37; test set: -0.49±0.30; p = 0.29).  
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With practice, patients showed better performance in the 9-HPT and cognitive tests, as well as 
improved levels of mood and fatigue (Table 3). This improvement did not correlate with the 
extent of home training related improvements (Table 3).   
 
Baseline MRI measures and their relationship with practice-related visuomotor 
improvements  
Functional MRI. In the training set, we identified SRT task-relevant regions, i.e., bilateral 
motor, premotor, visual and somatosensory cortices, as well as the right cerebellum (Fig. 3A, 
top). Sequence-specific signal changes were observed in the posterior parietal and visual cortices 
(Fig. 3A, bottom).  
When testing the relationship between functional responses in the SRT task>Rest contrast and 
Sequence-specific RT changes, i.e., the home training outcome, we found a significant 
correlation in the left cerebellar lobule VI (peak voxel coordinates in MNI space: -36, -60, -24; 
cluster size: 722 voxels), where BOLD signal change at baseline correlated with faster 
performance improvements (Fig. 3B, top). We did not find regions that showed the opposite 
relationship. 
Structural MRI and resting perfusion MRI. In the training set, there was no significant 
correlation between baseline MRI measures of GM integrity [GM volume and magnetisation 
transfer ratio (MTR)] or CBF and Sequence-specific RT changes. However, higher fractional 
anisotropy (FA) values in a wide range of WM tracts, including cortico-spinal tract, corpus 
callosum and longitudinal fasciculi, correlated significantly with home-practice outcome, i.e., 
higher FA values were associated with faster improvements in RT with practice (Fig. 3B, 
bottom).  
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Predictors of performance improvements with home practice 
Variable selection and parameter estimation (training set). Tables 1 and 2 list the clinical and 
MRI variables that were considered in the five modelling approaches for the predictive analysis. 
In each resulting model, between three and 13 variables were retained and contributed to the 
model to varying extents (Fig. 4). 
 
Model selection (validation set). For each model, we calculated the model error (MSE). The 
lowest model error in the validation set was found in model A (model A: 1.16, model B: 1.33, 
model C: 1.28, model D: 1.63, model E: 1.23). 
 
Model evaluation (test set). Model A was applied to the independent test set. The home-practice 
outcome predicted by model A significantly correlated with the actual outcome (r[21]=0.66, 
p<0.0001, Fig. 5) and could explain 44% of the variance. 
Based on these model parameters (regression coefficients in Fig. 4), the variables in model A 
predicted individual improvements with practice in upper limb performance according to the 
relationship:  
predicted outcome (z score) Y = Xβ  
where X is a row vector of predictor values and β is a column vector of their respective beta 
coefficients (Table 4). 
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DISCUSSION 
By combining baseline demographic, clinical and neuroimaging data, this study identified 
predictors of visuomotor performance improvements with training in individual MS patients. The 
strongest predictors were age, clinical characteristics such as disease duration, visuo-spatial 
abilities, upper limb dexterity and self-evaluated disease impact, and the presence of DMT. MRI 
metrics did not predict the training outcome over and above these measures, but variation in 
brain activity and WM microstructure in regions relevant to the practised task explained 
individual differences in training outcome.  
 
Visuomotor training to probe upper limb functional recovery 
A four-week standardised visuomotor training intervention probed brain plasticity underlying 
functional recovery. Compliance was high, with a dropout rate of less than 20%. Patients varied 
in the number of trained days, but this did not affect the outcome measure. 
Interventional studies rely on the patient’s compliance with the intervention procedures. We 
monitored compliance by recording the log file of each session of intervention and by asking the 
patients to complete a diary to record specific deviations from the daily protocol or factors 
affecting the practice. We mitigated the effect of variability in task execution by defining an 
outcome measure that is independent of the total number of practice sessions completed. 
While, as a group, patients significantly improved performance with practice, the training 
outcome varied considerably between patients, reflecting the heterogeneity in functional 
recovery and rehabilitation outcomes observed in real-life setting. The distribution of 
performance improvements (Figure 5) suggested a continuum rather than distinct groups of 
responders versus non-responders. Therefore, our modelling predicted the extent of performance 
improvement, without attempting an arbitrary classification of patients into groups. 
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Our contrast-derived training outcome, i.e., slope of Sequence-specific RT changes, allowed us 
to limit the confounding effect of attention, fatigue or motivation on performance, thus capturing 
more stable changes in visuomotor performance21. Although our intervention was not 
individually tailored, as it would be in clinical rehabilitation, it facilitated generalizability and 
interpretability of the results by allowing all patients to experience the same, controlled training 
conditions. Indeed, the biological processes underlying clinically-induced or experimentally-
driven improvements in performance largely overlap. Firstly, rehabilitation leads to functional 
recovery that, in most cases, is sub-served by brain changes similar to those occurring with skill 
learning9. Secondly, Sequence-specific improvements with training, closely reflecting task-
oriented practice in rehabilitation, rely on systems involved in visuomotor integration and 
learning of movement sequences, functions that are relevant in rehabilitation3. Although this 
study was not designed to test explicitly a generalisation of effect of our intervention on 
routinely used clinical measures, changes in hand dexterity that accompanied performance 
improvements with practice suggest a possible, although small, clinical benefit of our 
experimental intervention.  
 
Predictors of performance improvements 
We used a statistical learning approach to identify predictors of visuomotor performance 
improvements, as a conventional linear regression could lead to overfitting, i.e., the resulting 
model could work well for the data that was used to establish the model, but not for independent 
data.  
Within the most successful predictive model (model A), the strongest predictor was performance 
of SDMT, a measure of visuo-spatial skills and speed of processing that is considered to be 
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powerful tool to assess cognition in MS22. Patients with higher SDMT performance showed 
faster visuomotor performance improvements with practice, extending the relevance of cognitive 
reserve from normal motor learning23 to functional recovery.  
Higher levels of hand dexterity predicted performance improvements, with scores of both hands 
contributing independently to the model. Although right-hand dexterity is directly relevant to the 
execution of the study intervention, left hand dexterity in MS may also reflect the function of the 
left motor regions, thus contributing to explain the independent predictive role of the left upper 
limb function  in performance improvements of the right upper limb24.  
Our results also suggest that younger age, higher pre-morbid reserve, lower disease burden, as 
assessed formally and by self-report, and modulation of inflammation predict patients who will 
improve performance with practice. Since our intervention relies on brain plasticity, these factors 
can also act as determinants of the intervention success, as they can be associated with 
building25, maintaining26 and exploiting27 plastic reserve in the patients. By contrast, pathological 
MS changes, from brain atrophy to vascular abnormalities, can contribute to reduce plastic 
reserve in patients with higher disease burden, adding to the effect of age on brain health5, 28.  
 
MRI correlates of performance improvements 
Performance improvements with training correlated significantly with baseline group-level 
structural and functional MRI measures. Higher FA in the longitudinal fasciculi, corticospinal 
tracts and corpus callosum was significantly associated with better home training outcome. 
These regions are important for visuomotor integration, inter-hemispheric communication and 
motor execution, functions all relevant to our visuomotor task29. These effects were widespread 
across white matter, suggesting that, along with the integrity of specific regions, the overall 
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microstructural health, which provides the substrate for local, as well as long-range connectivity 
and that is disrupted by MS damage30, 31, is beneficial to support full recovery. 
Patients with stronger cerebellar activation, as measured by BOLD fMRI during the SRT task, 
showed greater improvements with practice. A localised brain-behaviour relationship was found 
in cerebellar lobule VI, which is functionally connected with the contralateral higher motor 
control regions32. While the relationship between training outcomes and baseline SRT-related 
signal changes in the cerebellum may result from a simple modification of performance33, it 
could also suggest that stronger or more intact error processing function leads to better training 
outcomes34.  
At least within the range of damage and length of training studied here, brain MRI data did not 
predict the outcome over and above demographic and clinical data, confirming the difficulty in 
translating directly results from MRI group-level analyses to the individual patient and clinical 
practice and highlighting the importance of developing novel biologically-informative MRI-
based metrics to increase the potential of neuroimaging for single-subject prediction35. Some 
aspects of damage in our population, e.g., those revealed by other MRI methods (e.g., MR 
spectroscopy) or within other anatomical sites (e.g., spinal cord and optic nerve), may not have 
been fully captured. However, we aimed for a comprehensive, yet feasible baseline 
characterisation of brain function and structure in a single MRI session, and selected MRI 
methods and measurements, whose biological informativeness for MS damage, repair and 
systems-level plasticity is well established3. While we aimed to predict performance 
improvements from a single baseline assessment, it is possible that analysis of longitudinal 
clinical and MRI data could identify MRI predictors of functional recovery.  
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Conclusions 
A comprehensive formal, as well as self-reported, baseline clinical assessment offers a reliable 
indication of the likely extent of recovery of visuomotor function in individual MS patients, at 
least within the range of disabilities, times and activities studied here. Residual abilities are 
retained functions, sub-served by the individual functional reserve, i.e., the remaining capacity of 
the brain to cope with an increased behavioural demand36. Our results highlight the importance 
of extending the routine clinical assessment of current disability to include measures of residual 
abilities relevant for recovery. Prediction of functional recovery in individual patients can 
provide valuable information at an early stage regarding the likelihood of response to standard 
rehabilitation interventions, as well as the stratification of patients for recovery-oriented clinical 
trials. The identification of structural and functional imaging correlates of performance 
improvements in a large cohort of patients provides a strong rationale for further, more targeted 
exploration of neuroimaging predictors of recovery. 
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